Clinical Trials on Neoadjuvant Immunotherapy in United Kingdom
Total 28 results
-
Rutgers, The State University of New JerseyPfizer; American Cancer Society, Inc.CompletedImmunotherapy | Clinical TrialsUnited States
-
University of SouthamptonIsle of Wight NHS TrustCompletedAsthma | Immunotherapy | Allergy and ImmunologyUnited Kingdom
-
Adlai Nortye Biopharma Co., Ltd.CompletedNeoadjuvant Therapy in Rectal CancerUnited States, United Kingdom, Poland
-
ViomeAdventHealthRecruitingGynecologic Cancer | Immunotherapy | Gut MicrobiomeUnited States
-
Nemours Children's ClinicCompletedAllergy | ImmunotherapyUnited States
-
Johns Hopkins UniversityNational Institutes of Health (NIH)CompletedPharmacokinetics | Peanut Allergy | ImmunotherapyUnited States
-
Lumicell, Inc.National Cancer Institute (NCI); Massachusetts General HospitalTerminatedBreast Cancer | Neoadjuvant TherapyUnited States
-
Mayo ClinicCompletedBreast Cancer | Chemotherapy | Neoadjuvant Therapy | Hormone Replacement TherapyUnited States
-
Massachusetts General HospitalWithdrawnAnaphylaxis as a Result of Allergen or Venom ImmunotherapyUnited States
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical ProceduresCanada, United Kingdom, Spain, New Zealand
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
VA Office of Research and DevelopmentWayne State University; University of Michigan; Barbara Ann Karmanos Cancer InstituteCompletedNon-Small Cell Lung Cancer | ImmunotherapyUnited States
-
University of Wisconsin, MadisonBlue Earth DiagnosticsRecruitingBrain Metastasis | Radiation Therapy | Immunotherapy, ActiveUnited States
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
HonorHealth Research InstituteActive, not recruitingPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Unresectable Pancreatic Cancer | Neoadjuvant Pancreatic CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedLymphoma | Leukemia | Risk Factor, Cardiovascular | Cardiotoxicity | ImmunotherapyUnited States
-
Massachusetts General HospitalWashington University School of MedicineNot yet recruitingSkin Cancer | Actinic Keratoses | Immunotherapy | Cutaneous Squamous Cell Carcinoma | Organ Transplant RecipientsUnited States
-
Massachusetts General HospitalWashington University School of MedicineNot yet recruitingSkin Cancer | Actinic Keratoses | Immunotherapy | Cutaneous Squamous Cell Carcinoma | Organ Transplant RecipientsUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Northwestern UniversityRecruitingOvarian Cancer | Prehabilitation | Neoadjuvant ChemotherapyUnited States
-
Rush University Medical CenterWithdrawnImmunotherapy | Cancer of Skin | Exercise, Aerobic | Cancer of Kidney | Cancer of BladderUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedCytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy PatientsUnited States
-
Advaxis, Inc.CompletedEffects of Immunotherapy | Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Cervical Small Cell Carcinoma | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Metastatic/Recurrent Cervical Cancer | Cervical Adenosquamous Cell CarcinomaUnited States
-
VM Oncology, LLCRecruitingSarcoma | Cervical Cancer | Breast Cancer | Adenoid Cystic Carcinoma | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Thymic Carcinoma | Lung Cancer | Mesothelioma | Bladder Cancer | Head and Neck Carcinoma | Any Solid Tumors Progressed After a Prior ImmunotherapyUnited States, Puerto Rico
-
NanobiotixRecruitingMetastatic Renal Cell Carcinoma | Squamous Cell Carcinoma of Head and Neck | Radiotherapy | Immunotherapy | Microsatellite Instability-High Solid Malignant Tumour | Metastasis From Malignant Tumor of Liver | Metastasis From Malignant Tumor of Cervix | Metastasis From Malignant Melanoma of Skin (Disorder) and other conditionsUnited States
-
Massachusetts General HospitalConquer Cancer FoundationActive, not recruitingStage IV Non-Small Cell Lung Cancer | Stage IV Bladder Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Immunotherapy | Immune Checkpoint Inhibitors | Stage IV Gastric Cancer | Stage IV Merkel Cell Carcinoma | Stage IV Colorectal Cancer | Stage IV Esophageal Cancer | Advanced Lung Cancer | Stage IV Renal... and other conditionsUnited States